Navigation Links
AIDS Drugs Don't Need Routine Lab Monitoring
Date:12/9/2009

Finding is good news for first-line treatment in Africa, researchers say

WEDNESDAY, Dec. 9 (HealthDay News) -- In a finding that has implications for how the AIDS virus is treated in Africa, new research suggests that antiretroviral drugs can be given without routine monitoring by lab tests.

But tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment, the study authors report.

Patients with HIV, the virus that causes AIDS, often receive drug treatment in Africa without routine laboratory monitoring. In the study, published online Tuesday in advance of publication in a future print issue of The Lancet, researchers tried to determine if that's a bad idea.

They studied 3,316 HIV-positive adults who were assigned to monitoring in both the doctor's office and the laboratory or only in the doctor's office. The patients were studied in Uganda and Zimbabwe.

"The results clearly show that first-line [antiretroviral therapy, or ART] can be delivered safely without routine biochemistry and hematology monitoring for toxic effects, but that routine CD4-cell count monitoring has a small but significant benefit in terms of disease progression and mortality, probably owing to slightly earlier switching to second-line ART," the researchers wrote.

More information

Avert has more about AIDS in Africa.



-- Randy Dotinga



SOURCE: The Lancet, news release, Dec. 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs
2. Case Western Reserve to receive $19.7m to study tuberculosis treatment drugs
3. OrderOnlineDrugs.com Makes Ordering Drugs Online Safe and Affordable
4. Second-line CML drugs evoke faster response than front-line therapy
5. Hormonal Drugs Cool Hot Flashes From Prostate Cancer Therapy
6. Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD
7. Diabetes Drugs Go Head-to-Head in Study
8. drugstore.com Continues Global Sales Expansion to More Than 3.5 Billion International Consumers
9. China Nepstar Chain Drugstore Reports 92.1% Year-on-Year Increase in Operating Income for Third Quarter 2009
10. Coverage of inexpensive drugs may increase length and quality of life after heart attack
11. Gene increases effectiveness of drugs used to fight cancer and allows reduction in dosage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Viejo, California (PRWEB) , ... January 20, 2017 , ... ... easy to use inside of Final Cut Pro X," said Christina Austin - CEO ... on the RED Dragon. Utilizing the Dragon Sensor,TransFlare 4K Mystique lens flare and light ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than ... the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” ... career as an educator interacting with countless women who had little knowledge of the ...
(Date:1/20/2017)... ... , ... “Code Word: Chocolate Biscuit”: a biographical account following a man who went on to ... published author, Marlyn Ivey, born in Lynn Haven, Florida and at the age of 5, ... years of age, he joined the Navy and got married right out of boot camp. ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in a study indicating ... Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive Expiratory Pressure Devices ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
(Date:1/19/2017)...  Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage ... announced new additions to its senior leadership team: ... and Daniel Geffken as interim Chief Financial ... , Pharm.D. has been promoted to Chief Clinical Development ... Doug and Daniel to our management team, as both ...
Breaking Medicine Technology: